BIOX Stock 12 Month Analyst Forecast
Eps Overview
Growth Next 5yrs
N/A
Last Quarter
- $0.12
Past Year
- $0.92
Growth Past 5yrs
N/A
Next Quarter
$0.07
Estimate Next Year
$88.88
Consensus Rating
Loading...
Consensus Price Target
Highest Price Target
$12.00
809.09% Upside
Mean Price Target
$6.16
366.38% Upside
Lowest Price Target
$2.25
70.45% Upside
Recent Analyst Ratings
Upgrades, Downgrades, New Coverage
Actual EPS vs Estimated EPS
BIOX Earnings Per Share (EPS) History
According to financial reports, BIOX (NYSE: BIOX) reported an actual EPS of $-0.1183 for the quarter ending on Nov 12, 2025, compared to an estimated $0.07, resulting in a -269.00% surprise. In the prior quarter (Sep 09, 2025), BIOX recorded an actual EPS of $-0.7 with a -800.00% surprise. See BIOX's full earnings history.
Earnings History
EPS Surprise Factor Analysis
BIOX has experienced notable EPS surprises, with the latest quarter ending Nov 12, 2025 showing a -269.00% miss. Previously, the quarter ending Sep 09, 2025 recorded a -800.00% miss. An EPS surprise factor indicates how much actual earnings deviate from analyst forecasts.
Frequently Asked Questions
Is BIOX stock getting favorable reviews from Wall Street analysts?
Brokerage firms have given BIOX stock an average recommendation of
Buy. 8 analysts have given their ratings
to BIOX out of which
2 analysts have given strong buy call,
4 analysts have given buy call,
2 analysts rate it hold,
0 analysts advocate strong sell call, and
0 analysts has given sell rating. The average target price of
$6.16 gives the stock implied upside
of roughly 366.38% over the next year or so.
What have analysts suggested for BIOX highest price target?
Analysts suggest BIOX's stock price would rise to a high of $12.00.
What is the lowest price target analysts expect for BIOX over the next year?
Within the next 12 months, analysts predict the BIOX stock price could move to $2.25.
What is the average target price for BIOX?
BIOX stock has an average analyst estimate of $6.16.
At its current price, how far is BIOX from its average target price?
BIOX shares are currently trading 366.38% above this price target.
What were BIOX’s actual earnings per share for the recent quarter?
Its quarterly earnings per share (EPS) came in at - $0.12 versus consensus estimates of $0.07, and below the comparable year-ago quarter’s EPS of - $0.09.
What are the current estimates for quarterly and annual earnings per share?
BIOX's forecasts by analysts estimating quarterly EPS at $0.07 and $88.88 for the whole year.
What has BIOX's growth been in the past five years and what is expected in the next five years?
The analysts have projected N/A EPS growth for BIOX in the next five years, compared to growth rates of N/A in the past five years.